Sergio Galvan-Vano
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 325 publications
Spironolactone versus Bicalutamide for Female Pattern Hair Loss: A 24-Month Unicenter Retrospective Comparative Study of Effectiveness and Safety.
Journal: Dermatology and therapy
Published: May 28, 2026
Tyrosine kinase 2 inhibition in alopecia areata: why deucravacitinib failed where others succeeded.
Journal: The British journal of dermatology
Published: April 20, 2026
Switching from deuruxolitinib to baricitinib in alopecia areata: a real-world cohort of 36 patients.
Switching from deuruxolitinib to baricitinib in alopecia areata: a real-world cohort of 36 patients.
Journal: Journal of the American Academy of Dermatology
Published: April 17, 2026
Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes.
Journal: Dermatology and therapy
Published: March 31, 2026
Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review.
Journal: Dermatology and therapy
Published: February 16, 2026
Sun Exposure and Photoprotection Knowledge, Habits, and Attitudes Among Spanish Military Personnel.
Journal: Photodermatology, photoimmunology & photomedicine
Published: February 06, 2026
Hair Aging Revisited: An Expert Delphi Consensus on Pathogenesis, Clinical Features, and Future Therapies.
Journal: Dermatology and therapy
Published: February 02, 2026
The Psychological Impact of Frontal Fibrosing Alopecia in Men: A Multicenter Cross-Sectional Study.
Journal: Skin appendage disorders
Published: January 15, 2026
Artificial Intelligence in Hair Disorders: A Narrative Review.
Journal: Dermatology and therapy
Published: January 07, 2026
Response to Yakaryilmaz et al, "Safety of low-dose oral minoxidil in the elderly population: The importance of assessing renal function and polypharmacy".
Journal: Journal of the American Academy of Dermatology
Published: December 02, 2025
Effectiveness of Botulinum Toxin Type A for Trichodynia Associated with Hair Loss Disorders: A Retrospective Study.
Journal: Dermatology and therapy
Published: December 01, 2025
A one-year exploratory randomized, controlled, multicentric pilot study evaluating the efficacy and tolerance of an anti-hair loss serum containing Silybum marianum extract, manganese PCA, and Lespedeza capitata extract following hair transplantation in men with androgenic alopecia.
Journal: Frontiers in medicine
Published: November 06, 2025
Last Updated: 09/26/2026